Aranesp is a medicine containing the active ingredient(s) darbepoetin alfa. On this page you will find out more about Aranesp, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: darbepoetin alfa
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Aranesp with Automatic Needle Guard 60 microgram/0.3 mL injection solution, 4 x 0.3 mL syringes
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Aranesp is indicated for the treatment of anaemia associated with chronic renal failure (CRF). Aranesp is also indicated for the treatment of anaemia and reduction of transfusion requirements in patients with non-myeloid malignancies where anaemia develops as a result of concomitantly administered chemotherapy
Table of characteristics
|Visual appearance||Clear colourless solution|
|Dosage Form||Injection, solution|
|Route of administration||Intravenous|
1 x syringe with automatic needle guard: Prescription Only Medicine, or Prescription Animal Remedy
4 x syringes with automatic needle guard: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store at 2 to 8 degrees Celsius|
|Storage conditions||Do not Freeze,Refrigerate|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 1 results
Aranesp | myVMC
Aranesp contain darbepoetin alfa. It is used in the treatment of anaemia due to chronic renal failure and prevention of anaemia in chemotherapy.
Read more on myVMC – Virtual Medical Centre website
Found 1 results
Erythropoietin or darbepoetin for patients with cancer | Cochrane
Researchers in The Cochrane Collaboration conducted a review of the effect of epoetin and darbepoetin for people with cancer. After searching for all relevant studies, they found 91 studies with up to 20,102 people. Their findings are summarized below:
Read more on Cochrane (Australasian Centre) website